RhumbLine Advisers’s CHELSEA THERAPEUTICS INT'L LTD CHTP Stock Holding History

RhumbLine Advisers’s Portfolio CHTP Stock Details CHTP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2014 Q2	–	Sell	-60,383	Closed	-$333K	–	3142
2014 Q1	$333K	Sell	60,383 -2,350	-4%	-$11.8K	﹤0.01%	2466
2013 Q4	$278K	Hold	62,733	–	–	﹤0.01%	2635
2013 Q3	$189K	Buy	62,733 +503	+0.8%	+$1.45K	﹤0.01%	2808
2013 Q2	$143K	Buy	+62,230	New	+$126K	﹤0.01%	3142

Other funds holding CHTP

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Whitebox Advisors Minneapolis, Minnesota $8.12B AUM 15.85% 1-Year Est. Return

PAMP

Polar Asset Management Partners Toronto, Ontario, Canada $5.01B AUM 35.27% 1-Year Est. Return

RhumbLine Advisers's CHTP Position: Q2 2014 in Review

RhumbLine Advisers sold out of CHELSEA THERAPEUTICS INT'L LTD (CHTP) in Q2 2014, closing a stake of 60,383 shares — an estimated $333K sold.

RhumbLine Advisers first reported a position in CHTP in Q2 2013 and held it in 4 quarters. The position peaked at $333K in Q1 2014. 6 funds tracked by Wall St. Rank hold CHTP as of Q2 2014.

RhumbLine Advisers reported no remaining CHELSEA THERAPEUTICS INT'L LTD position as of Q2 2014 after selling out during the quarter.
RhumbLine Advisers sold 60,383 CHELSEA THERAPEUTICS INT'L LTD shares in Q2 2014, an estimated $333K.
RhumbLine Advisers first reported a position in CHELSEA THERAPEUTICS INT'L LTD in Q2 2013 and held it in 4 quarters.
RhumbLine Advisers's CHELSEA THERAPEUTICS INT'L LTD position peaked at $333K in Q1 2014.
6 funds tracked by Wall St. Rank held CHELSEA THERAPEUTICS INT'L LTD as of Q2 2014.

Based on RhumbLine Advisers's 13F filing for Q2 2014, filed 6 Aug 2014.